Search

Rury L Grisham

Examiner (ID: 4728)

Most Active Art Unit
2672
Art Unit(s)
2625, 2672
Total Applications
220
Issued Applications
194
Pending Applications
0
Abandoned Applications
26

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16839801 [patent_doc_number] => 20210147813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => DRUG SCREENING PLATFORM USING BIOMATERIAL SCAFFOLDS [patent_app_type] => utility [patent_app_number] => 17/045308 [patent_app_country] => US [patent_app_date] => 2019-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045308 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/045308
DRUG SCREENING PLATFORM USING BIOMATERIAL SCAFFOLDS Apr 2, 2019 Pending
Array ( [id] => 17004526 [patent_doc_number] => 20210235687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => CRYOPRESERVATION SOLUTION AND CRYOPRESERVATION METHOD [patent_app_type] => utility [patent_app_number] => 17/050722 [patent_app_country] => US [patent_app_date] => 2019-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5548 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050722 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/050722
CRYOPRESERVATION SOLUTION AND CRYOPRESERVATION METHOD Apr 1, 2019 Pending
Array ( [id] => 16916294 [patent_doc_number] => 20210189386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => NUCLEIC ACID CONSTRUCT, MEDICINAL COMPOSITION, ANTICANCER AGENT, ANTIVIRAL AGENT AND ANTIBACTERIAL AGENT [patent_app_type] => utility [patent_app_number] => 17/043138 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5363 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043138 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/043138
NUCLEIC ACID CONSTRUCT, MEDICINAL COMPOSITION, ANTICANCER AGENT, ANTIVIRAL AGENT AND ANTIBACTERIAL AGENT Mar 28, 2019 Pending
Array ( [id] => 16598428 [patent_doc_number] => 20210024959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => ENGINEERED IMMUNE EFFECTOR CELLS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/040951 [patent_app_country] => US [patent_app_date] => 2019-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43893 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040951 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/040951
ENGINEERED IMMUNE EFFECTOR CELLS AND USE THEREOF Mar 27, 2019 Pending
Array ( [id] => 16541042 [patent_doc_number] => 20200407455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => GENETICALLY MODIFIED CELLS AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 16/980961 [patent_app_country] => US [patent_app_date] => 2019-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14981 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980961 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/980961
GENETICALLY MODIFIED CELLS AND METHOD FOR PRODUCING SAME Mar 14, 2019 Pending
Array ( [id] => 16822546 [patent_doc_number] => 20210137839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY [patent_app_type] => utility [patent_app_number] => 16/970216 [patent_app_country] => US [patent_app_date] => 2019-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 113971 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970216 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/970216
COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY Feb 14, 2019 Pending
Array ( [id] => 16613945 [patent_doc_number] => 20210032598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => ACTIVATION-INDUCED TISSUE-EFFECTOR CELLS SUITABLE FOR CELL THERAPY AND EXTRACELLUAR VESICLES DERIVED THEREFROM [patent_app_type] => utility [patent_app_number] => 16/965835 [patent_app_country] => US [patent_app_date] => 2019-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7192 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965835 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/965835
ACTIVATION-INDUCED TISSUE-EFFECTOR CELLS SUITABLE FOR CELL THERAPY AND EXTRACELLUAR VESICLES DERIVED THEREFROM Jan 28, 2019 Pending
Array ( [id] => 16506418 [patent_doc_number] => 20200385674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => EFFICIENT DERIVATION OF STABLE PLURIPOTENT BOVINE EMBRYONIC STEM CELLS [patent_app_type] => utility [patent_app_number] => 16/960812 [patent_app_country] => US [patent_app_date] => 2019-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16746 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960812 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/960812
EFFICIENT DERIVATION OF STABLE PLURIPOTENT BOVINE EMBRYONIC STEM CELLS Jan 10, 2019 Pending
Array ( [id] => 17082386 [patent_doc_number] => 20210277392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => CHEMICALLY-MODIFIED GUIDE RNAS TO IMPROVE CRISPR-CAS PROTEIN SPECIFICITY [patent_app_type] => utility [patent_app_number] => 16/760868 [patent_app_country] => US [patent_app_date] => 2018-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20056 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760868 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/760868
CHEMICALLY-MODIFIED GUIDE RNAS TO IMPROVE CRISPR-CAS PROTEIN SPECIFICITY Nov 1, 2018 Pending
Array ( [id] => 16514189 [patent_doc_number] => 20200393447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => BIOSENSORS FOR MEASURING CELL SIGNALING IN STRESSED AND HEALTHY CELLS [patent_app_type] => utility [patent_app_number] => 16/629485 [patent_app_country] => US [patent_app_date] => 2018-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13785 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629485 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/629485
BIOSENSORS FOR MEASURING CELL SIGNALING IN STRESSED AND HEALTHY CELLS Jul 5, 2018 Abandoned
Array ( [id] => 18537786 [patent_doc_number] => 20230242886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => METHOD FOR IN VITRO REPROGRAMMING OF FIBROBLASTS INTO SERTOLI CELLS AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/257221 [patent_app_country] => US [patent_app_date] => 2018-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9949 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257221 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/257221
METHOD FOR IN VITRO REPROGRAMMING OF FIBROBLASTS INTO SERTOLI CELLS AND APPLICATION THEREOF Jul 2, 2018 Pending
Array ( [id] => 16112297 [patent_doc_number] => 20200208171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-02 [patent_title] => UNIVERSAL SELF-REGULATING MAMMALIAN CELL LINE PLATFORM FOR THE PRODUCTION OF BIOLOGICS [patent_app_type] => utility [patent_app_number] => 16/622509 [patent_app_country] => US [patent_app_date] => 2018-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35918 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622509 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/622509
UNIVERSAL SELF-REGULATING MAMMALIAN CELL LINE PLATFORM FOR THE PRODUCTION OF BIOLOGICS Jun 14, 2018 Pending
Array ( [id] => 15708815 [patent_doc_number] => 20200101173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-02 [patent_title] => Genome Editing System For Repeat Expansion Mutation [patent_app_type] => utility [patent_app_number] => 16/622739 [patent_app_country] => US [patent_app_date] => 2018-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45923 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622739 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/622739
Genome Editing System For Repeat Expansion Mutation Jun 13, 2018 Pending
Array ( [id] => 15711191 [patent_doc_number] => 20200102361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-02 [patent_title] => VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR 21 (FGF21) CODING SEQUENCE [patent_app_type] => utility [patent_app_number] => 16/615854 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615854 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/615854
VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR 21 (FGF21) CODING SEQUENCE May 23, 2018 Abandoned
Array ( [id] => 15988743 [patent_doc_number] => 20200170242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => CELL CRYOPRESERVATION FORMULATION AND CELL RECOVERY METHOD [patent_app_type] => utility [patent_app_number] => 16/616216 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616216 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/616216
CELL CRYOPRESERVATION FORMULATION AND CELL RECOVERY METHOD May 23, 2018 Pending
Array ( [id] => 13778749 [patent_doc_number] => 20190002913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE TREATMENT OF ACHROMATOPSIA AND OTHER DISEASES [patent_app_type] => utility [patent_app_number] => 15/960048 [patent_app_country] => US [patent_app_date] => 2018-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11961 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15960048 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/960048
PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE TREATMENT OF ACHROMATOPSIA AND OTHER DISEASES Apr 22, 2018 Pending
Array ( [id] => 16779363 [patent_doc_number] => 20210116441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => New Uses Of Mammalian Muscle-Derived Stem Cells [patent_app_type] => utility [patent_app_number] => 16/604785 [patent_app_country] => US [patent_app_date] => 2018-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4379 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604785 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/604785
New Uses Of Mammalian Muscle-Derived Stem Cells Apr 8, 2018 Pending
Array ( [id] => 15832411 [patent_doc_number] => 20200131487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => COMPOSITION CONTAINING C2CL ENDONUCLEASE FOR DIELECTRIC CALIBRATION AND METHOD FOR DIELECTRIC CALIBRATION USING SAME [patent_app_type] => utility [patent_app_number] => 16/491208 [patent_app_country] => US [patent_app_date] => 2018-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491208 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/491208
COMPOSITION CONTAINING C2CL ENDONUCLEASE FOR DIELECTRIC CALIBRATION AND METHOD FOR DIELECTRIC CALIBRATION USING SAME Mar 5, 2018 Abandoned
Array ( [id] => 18932497 [patent_doc_number] => 11884905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Fluidic chip for cell culture use, culture vessel, and culture method [patent_app_type] => utility [patent_app_number] => 16/484506 [patent_app_country] => US [patent_app_date] => 2018-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 12594 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484506 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/484506
Fluidic chip for cell culture use, culture vessel, and culture method Jan 17, 2018 Issued
Menu